side effects of colonbroom glp-1 Booster Ingredients Investigated: 2026 Consumer Analysis Examines Colon Broom GLP-1 Formulation Disclosures Say bye to late-night cravings,

Developed by Eli Lilly, it represents the next evolution in pharmaceutical weight management, offering superior efficacy compared to dual-agonist therapies like tirzepatide

35 , e14586 (2023)

The Statistics: Who Is Using These Medications 1 in 8 Americans reported using a GLP-1 medication as of 2025 (Gallup National Health and Well-Being Index, 2025) 12.4% of Americans reported GLP-1 use in late 2025 more than double the 5.8% reported in February 2024 40 million+ GLP-1 prescriptions were written in the United States in 2024 alone Approximately 63% of patients who began Wegovy or Zepbound in early 2024 remained on therapy one year later, up from 40% among the 2023 cohort

Vita-Clariant complex with Vitamin C, Glutathione, Collagen